These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4309248)

  • 1. Visceral and behavioral responses to intraduodenal fat.
    Fara JW; Rubinstein EH; Sonnenschein RR
    Science; 1969 Oct; 166(3901):110-1. PubMed ID: 4309248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal hormones in mesenteric vasodilation after intraduodenal agents.
    Fara JW; Rubinstein EH; Sonnenschein RR
    Am J Physiol; 1972 Nov; 223(5):1058-67. PubMed ID: 4654340
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of atropine on the plasma cholecystokinin response to intraduodenal fat in man.
    Hopman WP; Jansen JB; Lamers CB
    Digestion; 1984; 29(1):19-25. PubMed ID: 6724165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of gastric motility by duodenal contents in turkeys.
    Duke GE; Evanson OA
    Poult Sci; 1972 Sep; 51(5):1625-36. PubMed ID: 4645730
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of secretion and pancreozymin on duodenal motility].
    Lanfranchi GA
    Minerva Gastroenterol; 1968; 14(4):197-204. PubMed ID: 5745797
    [No Abstract]   [Full Text] [Related]  

  • 6. Duodenal motility after cholecystokinin injection or satiety.
    Deutsch JA; Thiel TR; Greenberg LH
    Behav Biol; 1978 Nov; 24(3):393-9. PubMed ID: 743071
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of pure natural cholecystokinin on splanchnic circulation in the dog.
    Thulin L; Olsson P
    Acta Chir Scand; 1973; 139(8):681-6. PubMed ID: 4272342
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of pancreozymin and glucagon on gastro-duodenal motility in normal subjects.
    Stanciu C; Bennett JR
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):609-13. PubMed ID: 4453684
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of propofol and fentanyl on duodenal motility activity in pigs.
    Schnoor J; Unger JK; Kuepper T; Bode B; Hofeditz A; Silny J; Rossaint R
    Can Vet J; 2005 Nov; 46(11):995-1001. PubMed ID: 16363326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of secretin and pancreozymin on intracavitary pressure in the stomach and duodenum, evacuation from the stomach, and the tone of the pyloric sphincter.
    Geller LI; Petrenko VF
    Hum Physiol; 1980; 6(1):64-8. PubMed ID: 7399540
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gastrin, cholecystokinin-pancreozymin, secretin and the interaction of the motor function of the stomach, duodenum and bile-secreting apparatus].
    Barashkova GM
    Fiziol Zh SSSR Im I M Sechenova; 1975 May; 61(5):763-73. PubMed ID: 1140468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of gastrointestinal hormones on duodenal motility in acute experiments].
    Petzold A; Ottinger A; Hammer J; Walter J
    Gastroenterol J; 1991; 51(2):81-92. PubMed ID: 1684502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of CCK in avian gastroduodenal motility: evidence for nitric oxide involvement.
    Martinez V; Jimenez M; Goñalons E; Vergara P
    Am J Physiol; 1993 Nov; 265(5 Pt 1):G842-50. PubMed ID: 7902011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal motility after infusion of arachis oil into duodenum and ileum of dogs.
    Eeckhout C; De Wever I; Vantrappen G
    Dig Dis Sci; 1984 Feb; 29(2):164-70. PubMed ID: 6697857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cholecystokinin on duodenal motility.
    Dahlgren S
    Acta Chir Scand; 1967; 133(5):403-5. PubMed ID: 6053156
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs.
    Fung LC; Chisholm C; Greenberg GR
    Endocrinology; 1998 Jan; 139(1):189-94. PubMed ID: 9421414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric motility by a commercial duodenal mucosal extract containing cholecystokinin and pancreozymin.
    Johnson LP; Magee DF
    Nature; 1965 Sep; 207(5004):1401. PubMed ID: 5886051
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of leptin on cat intestinal motility.
    Gaigé S; Abysique A; Bouvier M
    J Physiol; 2003 Jan; 546(Pt 1):267-77. PubMed ID: 12509494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of secretin and cholecystokinin on the duodenal motility in man.
    Osnes M
    Scand J Gastroenterol Suppl; 1975; 35():22-5. PubMed ID: 1060164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.